Lewis Clayton Cantley Jr., Director at AGIOS PHARMACEUTICALS INC (AGIO), sold 2,000 shares at $56.61 ($114K) on 2017-08-22, disclosed to the SEC on 2017-08-24.
Scheduled sale ($114k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.61 | 500 | $28K | 24.9% |
| 2 | $56.63 | 500 | $28K | 24.9% |
| 3 | $57.07 | 500 | $29K | 25.1% |
| 4 | $57.09 | 500 | $29K | 25.1% |
| Total | $56.85 avg | 2,000 | $114K | 100% |
| Filing → |
| AGIO | SELL | 2017-10-18 | $142K | — | Filing → |
| AGIO | SELL | 2017-09-15 | $131K | — | Filing → |
| AGIO | SELL | 2017-07-21 | $254K | — | Filing → |